XML 33 R8.htm IDEA: XBRL DOCUMENT

Certain Balance Sheet Accounts

9 Months Ended

Sep. 30, 2019

Note 3—Certain Balance Sheet Accounts

Accounts Receivable, net

Accounts receivable, net consist of the following:


	September 30,		December 31,
	2019		2018
	(In thousands)
Trade receivables, net	$	29,809	$	22,654
Sublease and other receivables		122		164
Total accounts receivables, net	$	29,931	$	22,818

Trade receivables are shown net of $1.5 million and $0.4 million of chargeback and product return allowances as of September 30, 2019 and December 31, 2018, respectively.

Inventory

Inventory consists of the following:


	September 30,		December 31,
	2019		2018
	(In thousands)
Raw materials	$	43	$	83
Work-in-progress		379		—
Finished goods		751		5
Total inventory	$	1,173	$	88

Property and Equipment, Net

Property and equipment, net consists of the following:


	September 30,		December 31,
	2019		2018
	(In thousands)
Finance leases	$	4,920	$	4,034
Laboratory equipment		2,828		2,569
Computer equipment		921		862
Office equipment and furniture		625		625
Total cost		9,294		8,090
Less accumulated depreciation and amortization		(5,507)		(4,245)
Total property and equipment, net	$	3,787	$	3,845

For the nine months ended September 30, 2019 and 2018, depreciation and amortization expenses were $1.3 million and $0.7 million, respectively.

Accrued Expenses

Accrued expenses consist of the following:


	September 30,		December 31,
	2019		2018
	(In thousands)
Contract research and development	$	10,559	$	12,012
Sales rebates, fees and discounts		9,691		8,075
Interest payable		4,922		1,677
Employee compensation		3,371		2,714
Consulting and professional fees		3,162		3,669
Clinical trials		1,432		820
Other accrued expenses		859		1,219
Total accrued expenses	$	33,996	$	30,186